Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.65
-0.18-9.62%
Last update: Oct 5, 7:31 PM
$1.67
-0.15-8.24%
Anavex Life Sciences Corp (AVXL) Stock Price, Quote, News & History
AVXLNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Anavex Life Sciences (NASDAQ:AVXL) through any online brokerage.
Other companies in Anavex Life Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Anavex Life Sciences has a consensus price target of $30.00.
The stock price for Anavex Life Sciences (NASDAQ: AVXL) is $1.67 last updated October 5, 2026 at 7:31 PM EDT.
There are no upcoming dividends for Anavex Life Sciences.
Anavex Life Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Anavex Life Sciences.
Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
